{
  "title": "Antidepressants and Naltrexone for Stimulant Use Disorder",
  "itunes:title": "Antidepressants and Naltrexone for Stimulant Use Disorder",
  "pubDate": "Sat, 11 Jun 2022 16:00:56 +0000",
  "guid": "260701ba-3a2b-4e82-a3eb-fde055502a80",
  "link": "https://psychopharmacology.libsyn.com/antidepressants-and-naltrexone-for-stimulant-use-disorder",
  "itunes:image": "",
  "description": "<p>This episode discusses the evidence of mirtazapine, bupropion, and naltrexone for stimulant use disorder. Are these promising treatments? Are they really effective? </p> <p>Faculty: Andrew Saxon, M.D. <br /> Host: Jessica Diaz, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC164\"> <strong>Learn more about our memberships here</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/pharmacotherapies-for-stimulant-use-disorder-2622?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC164\"> <strong>Earn 1 CME: <span class=\"notion-enable-hover\" data-token-index=\"1\" data-reactroot=\"\">Experimental Pharmacotherapies for Stimulant Use Disorder</span></strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/antidepressants-and-naltrexone-for-methamphetamine-use-disorder-2622-5129?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC164\"> <strong><span class=\"notion-enable-hover\" data-token-index=\"1\" data-reactroot=\"\">Antidepressants and Naltrexone for Methamphetamine Use Disorder</span></strong></a></li> </ul>",
  "content:encoded": "<p>This episode discusses the evidence of mirtazapine, bupropion, and naltrexone for stimulant use disorder. Are these promising treatments? Are they really effective? </p> <p>Faculty: Andrew Saxon, M.D.  Host: Jessica Diaz, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC164\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/pharmacotherapies-for-stimulant-use-disorder-2622?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC164\"> Earn 1 CME: Experimental Pharmacotherapies for Stimulant Use Disorder</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/antidepressants-and-naltrexone-for-methamphetamine-use-disorder-2622-5129?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC164\"> Antidepressants and Naltrexone for Methamphetamine Use Disorder</a></li> </ul>",
  "enclosure": "",
  "itunes:duration": "11:07",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "This episode discusses the evidence of mirtazapine, bupropion, and naltrexone for stimulant use disorder. Are these promising treatments? Are they really effective?  Faculty: Andrew Saxon, M.D.  Host: Jessica Diaz, M.D.",
  "itunes:episodeType": "full"
}